| abstract |
The present invention discloses a combination, pharmaceutical composition and treatment method for treating prostate cancer. The combination disclosed in the present invention is one of the benzoheterocyclic compounds represented by the general formula (I), pharmaceutically acceptable salts, solvates, crystalline forms, co-crystals, stereoisomers, isotopic compounds, metabolites and prodrugs thereof And androgen receptor pathway modulators. The combination of the present invention, its pharmaceutical composition and treatment method can more effectively inhibit prostate cancer. |